Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Perez

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2022
Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practiceFernando Gomollón, Daniel Seoane-Mato, Miguel A Montoro, et al.
The Journal of General Virology|October 18, 2024
A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsidsJohn D Clarke, Helen M E Duyvesteyn, Eva Perez-Martin, et al.
Nature Structural & Molecular Biology|September 22, 2015
Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine designAbhay Kotecha, Julian Seago, Katherine Scott, et al.
Pharmacogenetics and Genomics|March 27, 2014
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritisAriana Montes, Eva Perez-Pampin, Javier Narváez, et al.
Cancer Cell|December 25, 2018
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic FactorsPanagiotis Karras, Erica Riveiro-Falkenbach, Estela Cañón, et al.
Pharmacogenomics|April 1, 2015
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitorsAriana Montes, Eva Perez-Pampin, Beatriz Joven, et al.
Arthritis Research & Therapy|March 19, 2009
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibilityRebeca Dieguez-Gonzalez, Manuel Calaza, Eva Perez-Pampin, et al.
Frontiers in Immunology|October 7, 2022
A catalog of the genetic causes of hereditary angioedema in the Canary Islands (Spain)Alejandro Mendoza-Alvarez, Eva Tosco-Herrera, Adrian Muñoz-Barrera, et al.
Arthritis Research & Therapy|October 12, 2018
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASERJuan José Bethencourt Baute, Carlos Sanchez-Piedra, Dolores Ruiz-Montesinos, et al.
Arthritis Research & Therapy|September 28, 2014
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control studyAida Ferreiro-Iglesias, Manuel Calaza, Eva Perez-Pampin, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2022
Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practiceFernando Gomollón, Daniel Seoane-Mato, Miguel A Montoro, et al.
The Journal of General Virology|October 18, 2024
A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsidsJohn D Clarke, Helen M E Duyvesteyn, Eva Perez-Martin, et al.
Nature Structural & Molecular Biology|September 22, 2015
Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine designAbhay Kotecha, Julian Seago, Katherine Scott, et al.
Pharmacogenetics and Genomics|March 27, 2014
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritisAriana Montes, Eva Perez-Pampin, Javier Narváez, et al.
Cancer Cell|December 25, 2018
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic FactorsPanagiotis Karras, Erica Riveiro-Falkenbach, Estela Cañón, et al.
Pharmacogenomics|April 1, 2015
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitorsAriana Montes, Eva Perez-Pampin, Beatriz Joven, et al.
Arthritis Research & Therapy|March 19, 2009
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibilityRebeca Dieguez-Gonzalez, Manuel Calaza, Eva Perez-Pampin, et al.
Frontiers in Immunology|October 7, 2022
A catalog of the genetic causes of hereditary angioedema in the Canary Islands (Spain)Alejandro Mendoza-Alvarez, Eva Tosco-Herrera, Adrian Muñoz-Barrera, et al.
Arthritis Research & Therapy|October 12, 2018
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASERJuan José Bethencourt Baute, Carlos Sanchez-Piedra, Dolores Ruiz-Montesinos, et al.
Arthritis Research & Therapy|September 28, 2014
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control studyAida Ferreiro-Iglesias, Manuel Calaza, Eva Perez-Pampin, et al.
Pageof 10